Scientists study blood and lung fluid to unlock secrets of ICU illnesses
NCT ID NCT05591924
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is observing 1,000 critically ill ICU patients to learn how their bodies respond to life-threatening infections and injuries. Researchers will collect blood and lung fluid samples to identify biological factors that could lead to earlier diagnosis and new treatments for conditions like sepsis and ARDS. Participants must be adults admitted to the ICU within the last 48 hours.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors diagnose critical illnesses earlier and discover new treatments for conditions like sepsis and ARDS.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data but does not test any therapy, so direct patient benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aleks Leligdowicz
RECRUITINGLondon, Ontario, N6A 3K7, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- AI may predict transfusion needs to shield ICU patients from organ failure
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Could a stress hormone be behind the hidden danger of low blood sugar?
- A simple blood test trend may flag ICU patients at risk